{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:34:54Z","timestamp":1783114494942,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","award":["70112499"],"award-info":[{"award-number":["70112499"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["2019 23760"],"award-info":[{"award-number":["2019 23760"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","award":["D15D18000410001"],"award-info":[{"award-number":["D15D18000410001"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009885","name":"Regione Piemonte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009885","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jmoldx.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T16:54:17Z","timestamp":1618937657000},"page":"834-846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9887-7668","authenticated-orcid":false,"given":"Luca","family":"Bertero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisella","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giammarco","family":"Collemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Koelsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Stichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schrimpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Flucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iver","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vokuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Fr\u00f6hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bironzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio V.","family":"Scagliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1977-7410","authenticated-orcid":false,"given":"Paola","family":"Cassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"von Deimling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2021.04.002_bib1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.21037\/tlcr.2018.10.02","article-title":"Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations","volume":"7","author":"De Bondt","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12940-018-0439-1","article-title":"Mortality among workers exposed to asbestos at the shipyard of Genoa, Italy: a 55 years follow-up","volume":"17","author":"Merlo","year":"2018","journal-title":"Environ Health"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","article-title":"The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050","volume":"92","author":"Hodgson","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/his.13073","article-title":"Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma","volume":"70","author":"Kushitani","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib6","doi-asserted-by":"crossref","first-page":"902","DOI":"10.5858\/arpa.2017-0537-RA","article-title":"The diagnosis of pleural tumors other than mesothelioma","volume":"142","author":"Attanoos","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/bjc.2011.104","article-title":"Markers for the non-invasive diagnosis of mesothelioma: a systematic review","volume":"104","author":"van der Bij","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib8","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3389\/fonc.2020.01742","article-title":"The use of immunohistochemistry, fluorescence in situ hybridization, and emerging epigenetic markers in the diagnosis of malignant pleural mesothelioma (MPM): a review","volume":"10","author":"Rozitis","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib9","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/PAS.0000000000001565","article-title":"The separation of benign and malignant mesothelial proliferations: new markers and how to use them","volume":"44","author":"Churg","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib10","first-page":"2108","article-title":"Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas","volume":"9","author":"Illei","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib11","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1309\/E2AAY2XXN431WL81","article-title":"p16INK4A (CDKN2A) gene deletion is a frequent genetic event in synovial sarcomas","volume":"126","author":"Subramaniam","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrg.2017.57","article-title":"The interplay of epigenetic marks during stem cell differentiation and development","volume":"18","author":"Atlasi","year":"2017","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","article-title":"Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience","volume":"136","author":"Capper","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib15","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1002\/cncr.31583","article-title":"Advances in the classification of pediatric brain tumors through DNA methylation profiling: from research tool to frontline diagnostic","volume":"124","author":"Kumar","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/nan.12610","article-title":"Brain tumour diagnostics using a DNA methylation-based classifier as a diagnostic support tool","volume":"46","author":"Priesterbach-Ackley","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","article-title":"Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib18","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","article-title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"69","author":"Goto","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lungcan.2004.08.003","article-title":"Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung","volume":"47","author":"Tsou","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib20","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1158\/0008-5472.CAN-09-1073","article-title":"Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00401-018-1871-6","article-title":"Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations","volume":"136","author":"Koelsche","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13569-019-0113-6","article-title":"Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype","volume":"9","author":"Koelsche","year":"2019","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00401-013-1126-5","article-title":"Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays","volume":"125","author":"Hovestadt","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","article-title":"Hierarchical grouping to optimize an objective function","volume":"58","author":"Ward","year":"1963","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib25","first-page":"2579","article-title":"Visualizing data using t-SNE","volume":"9","author":"van der Maaten","year":"2008","journal-title":"J Mach Learn Res"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib26","first-page":"401","article-title":"Medico-legal aspects of mesothelioma","volume":"78","author":"Partemi","year":"2007","journal-title":"Ann Ital Chir"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/10937404.2016.1195323","article-title":"Mesothelioma from asbestos exposures: epidemiologic patterns and impact in the United States","volume":"19","author":"Lemen","year":"2016","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib28","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jtho.2019.06.020","article-title":"Pathologic considerations and standardization in mesothelioma clinical trials","volume":"14","author":"Tsao","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/PAP.0000000000000180","article-title":"Recent advances in the diagnosis of malignant mesothelioma: focus on approach in challenging cases and in limited tissue and cytologic samples","volume":"25","author":"Monaco","year":"2018","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib31","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jtho.2017.02.004","article-title":"Is mesothelioma in China rare or misdiagnosed?","volume":"12","author":"John","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00401-019-01960-x","article-title":"Primary intracranial sarcomas with DICER1 mutation often contain prominent eosinophilic cytoplasmic globules and can occur in the setting of neurofibromatosis type 1","volume":"137","author":"Lee","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00401-019-01969-2","article-title":"Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA","volume":"137","author":"Hou","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000478-200105000-00007","article-title":"Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma","volume":"25","author":"Miettinen","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib38","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2021.04.002_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157821000908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157821000908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:07:28Z","timestamp":1778616448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157821000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1525157821000908"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2021.04.002","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}